Defining minimal clinically important differences (MCID) in chronic cough: Analyses of objective cough counts from a Phase 2 randomized controlled trial

Disease Areas:
Cough
Device Types:
VitaloJAK

This study analyzed data from a Phase 2 randomized controlled trial to define the minimal clinically important difference in cough count in 253 patients with chronic cough. 24-hour cough count was measured using the Vitalograph VitaloJAK device.

chevron_right View Article

Talk to our team